Altimmune (ALT) Non Operating Investment Income (2010 - 2012)
Altimmune (ALT) reported Non Operating Investment Income of $823809.0 for Q2 2012, up 19.7% year-over-year from $688221.0 in Q3 2011, and up 183.07% quarter-over-quarter from -$991662.0 in Q1 2012.
Altimmune (ALT) Non Operating Investment Income (2010 - 2012) Analysis & Trends
Altimmune (ALT) has 3 years of Non Operating Investment Income data on file, last reported at $823809.0 in Q2 2012.
- Non Operating Investment Income for Q2 2012 came in at $823809.0, up 19.7% year-over-year; the trailing twelve-month figure through Jun 2012 was $3.8 million (up 247.2% YoY), and the FY2011 annual result was $7.1 million, up 230.92% from the prior year.
- Non Operating Investment Income improved to $823809.0 in Q2 2012 per ALT's latest filing, from -$991662.0 in the prior quarter.
- Over five years, Non Operating Investment Income peaked at $2.9 million in Q3 2011 and troughed at -$5.8 million in Q4 2010.
- A 3-year average of $139120.4 and a median of $688221.0 in 2011 frame the typical range for Non Operating Investment Income.
- The sharpest annual moves came in 2011 and 2012: Non Operating Investment Income surged 3734.79% in 2011, then plunged 139.85% in 2012.
- A 3-year view of Non Operating Investment Income shows it stood at -$5.8 million in 2010, then jumped by 118.33% to $1.1 million in 2011, then declined by 22.97% to $823809.0 in 2012.
- Business Quant data shows ALT's Non Operating Investment Income at $823809.0 in Q2 2012, -$991662.0 in Q1 2012, and $1.1 million in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 230,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Altimmune | 336.67 Mn | 336.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2012 | 823,809.00 |
| Jun 30, 2012 | 823,809.00 |
| Mar 31, 2012 | -991,662.00 |
| Mar 31, 2012 | -991,662.00 |
| Dec 31, 2011 | 1.07 Mn |
| Dec 31, 2011 | 1.07 Mn |
| Sep 30, 2011 | 2.90 Mn |
| Sep 30, 2011 | 2.90 Mn |
| Jun 30, 2011 | 688,221.00 |
| Jun 30, 2011 | 688,221.00 |
| Mar 31, 2011 | 2.49 Mn |
| Mar 31, 2011 | 2.49 Mn |
| Dec 31, 2010 | -5.83 Mn |
| Dec 31, 2010 | -5.83 Mn |
| Sep 30, 2010 | 75,594.00 |
| Sep 30, 2010 | 75,594.00 |
| Jun 30, 2010 | 33,470.00 |
| Jun 30, 2010 | 33,470.00 |